Merck Animal Health agreed to acquire Vence Corp from a consortium of shareholders on September 22, 2022. The transaction is expected to close in the third quarter of 2022, subject to customary closing conditions.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2,906 GBX | +0.40% | +2.06% | +12.95% |
02:24pm | Pressure on gas and LNG prices to help switch from coal, says J.P. Morgan | RE |
01:53pm | SHELL (NEU) : JP Morgan reaffirms its Buy rating | ZD |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.95% | 231B | |
+20.34% | 479B | |
+40.89% | 251B | |
+9.98% | 174B | |
+11.31% | 107B | |
-7.59% | 78.64B | |
-0.89% | 53.04B | |
+26.05% | 50.35B | |
-.--% | 50.18B | |
+31.11% | 39.65B |
- Stock Market
- Equities
- SHEL Stock
- News Shell plc
- Merck Animal Health agreed to acquire Vence Corp from a consortium of shareholders.